Dummer R - Search Results

1

Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.

Hilbers ML, Dimitriou F, Lau P, Bhave P, McArthur GA, Zimmer L, Kudura K, Gérard CL, Levesque MP, Michielin O, Dummer R, Cheng PF, Mangana J. Hilbers ML, et al. Among authors: dummer r. Eur J Cancer. 2021 Oct;156:149-163. doi: 10.1016/j.ejca.2021.07.028. Epub 2021 Aug 25. Eur J Cancer. 2021. PMID: 34454317 Free article.

2

A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring.

Dummer R, Gore ME, Hancock BW, Guillou PJ, Grobben HC, Becker JC, Oskam R, Dieleman JP, Burg G. Dummer R, et al. Cancer. 1995 Feb 15;75(4):1038-44. doi: 10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f. Cancer. 1995. PMID: 7842406 Clinical Trial.

3

Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.

Wimmer I, Meyer JC, Seifert B, Dummer R, Flace A, Burg G. Wimmer I, et al. Among authors: dummer r. Cancer Res. 1997 Nov 15;57(22):5073-6. Cancer Res. 1997. PMID: 9371505

4

Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.

Heinzerling LM, Urbanek M, Funk JO, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R. Heinzerling LM, et al. Among authors: dummer r. Cancer. 2000 Oct 15;89(8):1835-44. Cancer. 2000. PMID: 11042581 Clinical Trial.

5

Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.

Zagrodnik B, Kempf W, Seifert B, Müller B, Burg G, Urosevic M, Dummer R. Zagrodnik B, et al. Among authors: dummer r. Cancer. 2003 Dec 15;98(12):2708-14. doi: 10.1002/cncr.11798. Cancer. 2003. PMID: 14669293 Free article.

6

Survival and prognostic factors in patients with brain metastases from malignant melanoma.

Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, Dummer R. Meier S, et al. Among authors: dummer r. Onkologie. 2004 Apr;27(2):145-9. doi: 10.1159/000076903. Onkologie. 2004. PMID: 15138346 Free article.

7

Molecularly targeted therapy for melanoma: current reality and future options.

Becker JC, Kirkwood JM, Agarwala SS, Dummer R, Schrama D, Hauschild A. Becker JC, et al. Among authors: dummer r. Cancer. 2006 Nov 15;107(10):2317-27. doi: 10.1002/cncr.22273. Cancer. 2006. PMID: 17039502 Free article. Review.

8

Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?

Dummer R, Assaf C, Bagot M, Gniadecki R, Hauschild A, Knobler R, Ranki A, Stadler R, Whittaker S. Dummer R, et al. Eur J Cancer. 2007 Nov;43(16):2321-9. doi: 10.1016/j.ejca.2007.06.015. Epub 2007 Aug 17. Eur J Cancer. 2007. PMID: 17707638 Review.

9

Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome.

Mangana J, Zipser MC, Conrad C, Oberholzer PA, Cozzio A, Knuth A, French LE, Dummer R. Mangana J, et al. Among authors: dummer r. Eur J Dermatol. 2008 Sep-Oct;18(5):566-70. doi: 10.1684/ejd.2008.0490. Epub 2008 Aug 8. Eur J Dermatol. 2008. PMID: 18693162 Free article.

10

Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Dummer R, Mangana J. Dummer R, et al. Biologics. 2009;3:169-82. doi: 10.2147/btt.2009.3051. Epub 2009 Jul 13. Biologics. 2009. PMID: 19707406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,011 results

Search Page